Mirk Regulates the Exit of Colon Cancer Cells from Quiescence
Open Access
- 1 August 2009
- journal article
- Published by Elsevier BV
- Vol. 284 (34), 22916-22925
- https://doi.org/10.1074/jbc.m109.035519
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Mirk/Dyrk1B Maintains the Viability of Quiescent Pancreatic Cancer Cells by Reducing Levels of Reactive Oxygen SpeciesCancer Research, 2009
- Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligaseNature, 2009
- Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cellsNature, 2009
- G0 Function of BCL2 and BCL-xL Requires BAX, BAK, and p27 Phosphorylation by Mirk, Revealing a Novel Role of BAX and BAK in Quiescence RegulationPublished by Elsevier BV ,2008
- TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen speciesThe Journal of Experimental Medicine, 2008
- ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivoProceedings of the National Academy of Sciences of the United States of America, 2008
- p53-Deficient Cells Rely on ATM- and ATR-Mediated Checkpoint Signaling through the p38MAPK/MK2 Pathway for Survival after DNA DamageCancer Cell, 2007
- Jack-of-All-Trades “Supergene” Controls Butterfly Wing Pattern DiversityPLoS Biology, 2006
- A New Description of Cellular QuiescencePLoS Biology, 2006
- Mirk/dyrk1B Is a Rho-induced Kinase Active in Skeletal Muscle DifferentiationJournal of Biological Chemistry, 2003